Martin Wagner
Neurology · Hermitage, TNNPI 1538172077
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 566 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 9.7% — the pattern of someone who eats at a lot of different presentations.
Across 566 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$939
- Biogen$902
- AbbVie$888
- UCB, Inc.$691
- Novartis$632
- Sunovion Pharmaceuticals Inc.$460
- plus $5K from 31 others
What the payments were for
- Speaking & faculty fees$801%
- Food & beverage$9,52598%
- Education$831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 42 | $939 |
| Biogen | 48 | $902 |
| AbbVie(2 entities) | 64 | $888 |
| UCB, Inc. | 28 | $691 |
| Novartis | 43 | $632 |
| Sunovion Pharmaceuticals Inc. | 27 | $460 |
| Eisai Inc. | 21 | $417 |
| Supernus Pharmaceuticals, Inc. | 52 | $407 |
| Teva Pharmaceuticals USA, Inc. | 28 | $334 |
| AstraZeneca | 12 | $332 |
| Amgen | 18 | $331 |
| EMD Serono, Inc. | 15 | $317 |
| SK Life Science, Inc. | 15 | $287 |
| Bausch Health US, LLC | 22 | $286 |
| Neurocrine Biosciences, Inc. | 7 | $254 |
| Acadia Pharmaceuticals Inc | 13 | $249 |
| Avanir Pharmaceuticals, Inc. | 11 | $235 |
| Genentech USA, Inc. | 12 | $177 |
| Lilly USA, LLC | 10 | $174 |
| Lundbeck LLC | 9 | $174 |
| Biohaven Pharmaceuticals, Inc. | 7 | $147 |
| Johnson & Johnson | 9 | $137 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $134 |
| Upsher-smith Laboratories LLC | 6 | $124 |
| Banner Life Sciences, LLC | 5 | $83 |
| Acorda Therapeutics, Inc | 4 | $80 |
| E.r. Squibb & Sons, L.L.C. | 5 | $78 |
| Grifols USA, LLC | 4 | $73 |
| Boston Scientific | 4 | $72 |
| Kyowa Kirin, Inc. | 3 | $60 |
| Aquestive Therapeutics, Inc. | 3 | $57 |
| Adamas Pharmaceuticals, Inc. | 2 | $38 |
| CSL Behring | 2 | $35 |
| Pfizer | 2 | $31 |
| Bristol Myers Squibb | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,688 in reported general payments places this provider in the 65th percentile of 361 neurology providers in Tennessee.
Other neurology in Hermitage
- Shan-Ren ZhouHermitage$28K
- Samuel HunterSpring Hill$676K
- Harold MosesNashville$438K
- Lucas ElijovichMemphis$415K
- David BrandesKnoxville$412K
- Sibyl WrayKnoxville$377K
- Christine HagenAlcoa$371K
- Mark LedouxMemphis$352K
- Christopher PendolaKingsport$344K
- Daniel ClaassenNashville$285K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.